Virax Biolabs Group Ltd
VRAX
查看详细走势图
0.370USD
+0.020+5.69%
收盘 12/24, 13:00（美东）报价延迟15分钟
2.42M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+5.69%
5天
-8.33%
1月
-2.81%
6月
-53.85%
今年开始到现在
-83.56%
1年
-78.49%
查看详细走势图
TradingKey Virax Biolabs Group Ltd股票评分
单位: USD 更新时间: 2025-10-27操作建议
当前估值合理，机构持股占比非常高，目前股价在压力位和支撑位之间，可以做区间波段操作。
Virax Biolabs Group Ltd评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
0
位分析师
--
评级
--
目标均价
--
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Virax Biolabs Group Ltd亮点
亮点风险
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
业绩增长期
公司处于发展阶段，最新年度总收入6.33K美元
估值高估
公司最新PE估值-0.36，处于3年历史高位
机构减仓
最新机构持股263.20K股，环比减少16.85%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓，最新持仓市值0.00
活跃度增加
近期活跃度增加，过去20天平均换手率0.02
Virax Biolabs Group Ltd新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Virax Biolabs Group Ltd简介
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
公司代码VRAX
公司Virax Biolabs Group Ltd
CEOFoster (James)
网址https://www.viraxbiolabs.com
常见问题
Virax Biolabs Group Ltd(VRAX)的当前股价是多少？
Virax Biolabs Group Ltd(VRAX)的当前股价是 0.370。
Virax Biolabs Group Ltd的股票代码是什么？
Virax Biolabs Group Ltd的股票代码是VRAX。
Virax Biolabs Group Ltd股票的52周最高点是多少？
Virax Biolabs Group Ltd股票的52周最高点是3.200。
Virax Biolabs Group Ltd股票的52周最低点是多少？
Virax Biolabs Group Ltd股票的52周最低点是0.350。
Virax Biolabs Group Ltd的市值是多少？
Virax Biolabs Group Ltd的市值是2.42M。
Virax Biolabs Group Ltd的净利润是多少？
Virax Biolabs Group Ltd的净利润为-6.06M。
现在Virax Biolabs Group Ltd(VRAX)的股票是买入、持有还是卖出？
根据分析师评级，Virax Biolabs Group Ltd(VRAX)的总体评级为--，目标价格为--。
Virax Biolabs Group Ltd(VRAX)股票的每股收益（EPS TTM）是多少
Virax Biolabs Group Ltd(VRAX)股票的每股收益（EPS TTM）是-1.625。
相关品种
